Back to Search Start Over

S183: PHASE III RANDOMIZED, MULTICENTER, OPEN-LABEL COMMODORE 1 TRIAL: COMPARISON OF CROVALIMAB VS ECULIZUMAB IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

Authors :
Phillip Scheinberg
Diego Cle
John Edwards
Valentina Giai
Marek Hus
Jin Seok Kim
Cristina Barrenetxea Lekue
Zsolt Nagy
Erfan Nur
Jens Panse
Yasutaka Ueda
Mustafa Nuri Yenerel
Anita Appius
Nadiesh Balachandran
Sammy Chebon
Brittany Gentile
Simon Buatois
Austin Kulasekararaj
Source :
HemaSphere, Vol 7, p e45540d8 (2023)
Publication Year :
2023
Publisher :
Wiley, 2023.

Subjects

Subjects :
Diseases of the blood and blood-forming organs
RC633-647.5

Details

Language :
English
ISSN :
25729241
Volume :
7
Database :
Directory of Open Access Journals
Journal :
HemaSphere
Publication Type :
Academic Journal
Accession number :
edsdoj.2d2502a5b31c44548849194a5c1b9631
Document Type :
article
Full Text :
https://doi.org/10.1097/01.HS9.0000967644.45540.d8
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details